Last reviewed · How we verify
Phenylephrine bolus
At a glance
| Generic name | Phenylephrine bolus |
|---|---|
| Sponsor | IWK Health Centre |
| Modality | Small molecule |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- The Choice of Vasopressor to Prevent Postoperative Acute Kidney Injury After Major Non-Cardiac Surgery (PHASE4)
- Acute and Chronic Repercussion of Spinal Cord Stimulation After Spinal Cord Injury (NA)
- Deciphering Preserved Autonomic Function After Multiple Sclerosis (NA)
- Comparison of Two Different Doses of Phenylephrine on Oxytocin Hemodynamic Effect (PHASE4)
- Longitudinal Autonomic Characterization as a Predictor for Secondary Medical Complications Post-SCI (NA)
- Deciphering Preserved Autonomic Function After Spinal Cord Injury (NA)
- Autoimmune Basis for Postural Tachycardia Syndrome (NA)
- Norepinephrine vs. Phenylephrine for Spinal Hypotension in Cesarean Section (NA)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Phenylephrine bolus CI brief — competitive landscape report
- Phenylephrine bolus updates RSS · CI watch RSS
- IWK Health Centre portfolio CI